Bristol-Myers Squibb to Present New Investigational Data on Orencia(R …

Published November 26, 2012

Bristol-Myers Squibb to Present New Investigational Data on Orencia(R …

Filed under: Drug Treatment Centers Denver Colorado

A first report of pooled safety data in Orencia SC & IV formulations based on the exposure of more than 6,000 patients, which examines the incidence rates and events reported with long-term Orencia treatment. — Long-term safety and efficacy of Orencia …
Read more on MarketWatch (press release)